264 related articles for article (PubMed ID: 36891151)
1. p53 mutation and deletion contribute to tumor immune evasion.
Liu S; Liu T; Jiang J; Guo H; Yang R
Front Genet; 2023; 14():1088455. PubMed ID: 36891151
[TBL] [Abstract][Full Text] [Related]
2. A Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development.
Shi D; Jiang P
Front Cell Dev Biol; 2021; 9():762651. PubMed ID: 34733856
[TBL] [Abstract][Full Text] [Related]
3. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H; Guo M; Wei H; Chen Y
Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
5. Functional Diversity of p53 in Human and Wild Animals.
Li Y; Zhang MC; Xu XK; Zhao Y; Mahanand C; Zhu T; Deng H; Nevo E; Du JZ; Chen XQ
Front Endocrinol (Lausanne); 2019; 10():152. PubMed ID: 30915036
[TBL] [Abstract][Full Text] [Related]
6. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications.
Wang M; Attardi LD
Annu Rev Pathol; 2022 Jan; 17():205-226. PubMed ID: 34699262
[No Abstract] [Full Text] [Related]
7. The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway.
Liu J; Zhang C; Wang J; Hu W; Feng Z
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182266
[TBL] [Abstract][Full Text] [Related]
8. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
9. Contribution of p53 to metastasis.
Powell E; Piwnica-Worms D; Piwnica-Worms H
Cancer Discov; 2014 Apr; 4(4):405-14. PubMed ID: 24658082
[TBL] [Abstract][Full Text] [Related]
10. p53, cancer and the immune response.
Blagih J; Buck MD; Vousden KH
J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 32144194
[TBL] [Abstract][Full Text] [Related]
11. ARF6 and AMAP1 are major targets of
Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
[TBL] [Abstract][Full Text] [Related]
12. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.
Malik N; Yan H; Yang HH; Ayaz G; DuBois W; Tseng YC; Kim YI; Jiang S; Liu C; Lee M; Huang J
PLoS Genet; 2021 May; 17(5):e1009553. PubMed ID: 33945523
[TBL] [Abstract][Full Text] [Related]
13. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
[TBL] [Abstract][Full Text] [Related]
14. p53 and brain tumors: from gene mutations to gene therapy.
Fulci G; Ishii N; Van Meir EG
Brain Pathol; 1998 Oct; 8(4):599-613. PubMed ID: 9804370
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor p53 and its mutants in cancer metabolism.
Liu J; Zhang C; Hu W; Feng Z
Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
[TBL] [Abstract][Full Text] [Related]
16. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.
Gnanapradeepan K; Basu S; Barnoud T; Budina-Kolomets A; Kung CP; Murphy ME
Front Endocrinol (Lausanne); 2018; 9():124. PubMed ID: 29695998
[TBL] [Abstract][Full Text] [Related]
17. Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging.
Li T; Liu X; Jiang L; Manfredi J; Zha S; Gu W
Oncotarget; 2016 Mar; 7(11):11838-49. PubMed ID: 26943586
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.
Hall JR; Messenger ZJ; Tam HW; Phillips SL; Recio L; Smart RC
Cell Death Dis; 2015 Mar; 6(3):e1700. PubMed ID: 25789975
[TBL] [Abstract][Full Text] [Related]
19. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
20. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K; Colbert JD; Rock KL
Front Immunol; 2021; 12():636568. PubMed ID: 33767702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
